References
- Babjuk M, Burger M, Compérat EM, et.al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) – 2019 update. Eur Urol. 2019;76(5):639–657.
- Dalbagni G, Vora K, Kaag M, et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol. 2009;56(6):903–910.
- Wang EYH, Larsson U, Gårdmark T, et al. Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? – A Swedish nationwide analysis. Scand J Urol. 2020.
- Pearl J. An introduction to causal inference. Int J Biostat. 2010;6:7.